SEC Form D · filed August 27, 2020
Kintara Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (27)
Laura Johnson · San Diego, CADirectorRobert Hoffman · San Diego, CADirectorScott Praill · San Diego, CAExecRobert Toth · San Diego, CADirectorSteven Rychnovsky · San Diego, CAExecJohn Liatos · San Diego, CAExec · DirectorSaiid Zarrabian · San Diego, CAExec · DirectorDennis Brown · San Diego, CAExecKeith Murphy · San Diego, CADirectorHideyuki J. Matsuda · PLYMOUTH MEETING, PAExecSteve A. Grosso · PLYMOUTH MEETING, PAExecThomas P. Cestare · PLYMOUTH MEETING, PADirectorGerald P. Plush · CORAL GABLES, FLExecBrian J. Piacentino · PLYMOUTH MEETING, PADirectorDonald P. Campbell · PLYMOUTH MEETING, PADirectorBruce R. Lesser · PLYMOUTH MEETING, PAExec · DirectorJoseph, Iii J. Lebel · PLYMOUTH MEETING, PADirectorDolores M. Lare · RADNOR, PAExec · DirectorBrandon C. O'Gara · Oklahoma City, OKDirectorEd Whitfield · New York, NYExecEddie Wilson · St. George, UTDirectorMichael C. Kanady · Oklahoma City, OKExecKate Khatib · New York, NYExec · DirectorJohn Odegard · Bellevue, WADirectorEugene A. Mcadams · Dallas, TXExecChristopher T. Frusco · Dallas, TXExec · DirectorChance T. Smith · Dallas, TXDirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗